HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce...
Read More Details
Finally We wish PressBee provided you with enough information of ( Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million )
Also on site :
- NYT ‘Connections’ Hints and Answers Today, Tuesday, May 20
- Man shot and killed after standoff with Columbus police during barricade incident
- Trump suggests coverup of Biden’s cancer as questions swirl over diagnosis